Fredun Pharma Allots 1,82,400 Equity Shares on Warrant Conversion

Fredun Pharmaceuticals Ltd has allotted 1,82,400 equity shares of face value Rs. 10/- each pursuant to the conversion of 60,800 warrants. This follows the payment of the balance consideration by warrant holders and approval from shareholders in an EGM held on October 22, 2025. The warrants were initially allotted on a preferential basis on December 29, 2025. The conversion and allotment were approved by the Board of Directors in a meeting held on October 03, 2026. The issue price per warrant was Rs. 1,250/-, with 25% payable upfront. Post a 1:2 bonus issue, the entitlement was adjusted, resulting in three equity shares per warrant upon payment of the balance consideration. The newly allotted shares will rank pari passu with existing equity shares.